Achilles tendon tendinopathy is a common musculoskeletal condition with clinical
difficulties for both clinicians and patients. This review describes current
management modalities, ranging from traditional methods such as eccentric
exercises, corticosteroid injection and shock wave therapy to more recent
approaches including biomaterials, nanotechnology, gene therapy and stem cells.
The advantages and limitations of the various approaches were highlighted, as well
as favorable research reports on the use of personalised treatments in chronic
diseases. The role of new technologies in improving therapeutic efficacy and
patients' quality of life, especially in the context of drug-resistant diseases, was
highlighted further. While significant issues were enumerated, such as high cost,
lesser accessibility of new therapies and lack of long-term follow-up to confirm their
efficacy and safety. The path of future research should involve the implementation
of these innovations into clinical practice, refinement of the treatment protocol to
optimize outcomes and the development of targeted medicine to improve the
management of Achilles tendinopathy.
Keywords: Tendinopathy, Achilles tendon, Conservative treatment, New
technologies